Clinical characterization of adult medulloblastoma and the effect of first-line therapies on outcome; The MD Anderson Cancer Center experience.
Nazanin K MajdMaximilan MastallHeather LinSeyede Shiva DibajKenneth R HessYing YuanManuela Martin-Bejarano GarciaGregory N FullerKristin D AlfaroMaria K Gule-MonroeJason T HuseSoumen KhatuaGanesh RaoDavid I SandbergJeffrey S WefelDebra N YeboaArnold C PaulinoSusan L McGovernWafik ZakyAnita MahajanDima SukiShiao-Pei WeathersRebecca A HarrisoJohn F De GrooVinay K PuduvalliMarta Penas-PradoPublished in: Neuro-oncology advances (2021)
This is the largest single-institution retrospective study of adult MB to our knowledge and identifies standard-risk status, first-line RT and adjuvant chemotherapy as factors associated with improved outcomes.